Table 3 Descriptive characteristics of adult CCS and controls (Study-2).
From: Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors
Adult CCS | Cases | Controls | ||||
|---|---|---|---|---|---|---|
n | % | n | % | pa | ||
All | 32 | 284 | ||||
Sex (female) | 22 | 68.8 | 188 | 66.2 | 0.77 | |
HL | 26 | 81.3 | ||||
Cancer site | Non-HL | 3 | 9.4 | |||
Testicular | 3 | 9.4 | ||||
Mean (SD) | Range | Mean (SD) | Range | pb | ||
Current age (years) | 42.6 (7.21) | 23.8–59.0 | 44.4 (6.76) | 23.0–62.4 | 0.21 | |
Time diagnosis to sample (years) | 22.3 (7.21) | 9.8–37.8 | – | – | – | |
